Hepatic serum- and glucocorticoid-regulated protein kinase 1 (SGK1) regulates insulin sensitivity in mice via extracellular-signal-regulated kinase 1/2 (ERK1/2).

Hao Liu,Junjie Yu,Tingting Xia,Yuzhong Xiao,Qian Zhang,Bin Liu,Yajie Guo,Jiali Deng,Yalan Deng,Shanghai Chen,Aniko Naray-Fejes-Toth,Geza Fejes-Toth,Feifan Guo

DOI: https://doi.org/10.1042/BJ20141005

IF: 3.766

2014-01-01

Biochemical Journal

Abstract:Insulin resistance is a major hallmark of metabolic syndromes, including Type 2 diabetes. Although numerous functions of SGK 1 (serum- and glucocorticoid-regulated kinase 1) have been identified, a direct effect of SGK 1 on insulin sensitivity has not been previously reported. In the present study, we generated liver-specific SGK1-knockout mice and found that these mice developed glucose intolerance and insulin resistance. We also found that insulin signalling is enhanced or impaired in Hep1-6 cells infected with adenoviruses expressing SGK1 (Ad-SGK1) or shRNA directed against the coding region of SGK1 (Ad-shSGK1) respectively. In addition, we determined that SGK1 inhibits ERK1/2 (extracellular-signal-regulated kinase 1/2) activity in liver and Ad-shERK 1/2-mediated inhibition of ERK1/2 reverses the attenuated insulin sensitivity in Ad-shSGK I mice. Finally, we found that SGK I functions are compromised under insulin-resistant conditions and overexpression of SGK I by Ad-SGK 1 significantly ameliorates insulin resistance in both glucosamine-treated HepG2 cells and livers of db/db mice, a genetic model of insulin resistance.